Clinical Trial Update: VAC069: A Study of Blood-stage Controlled Human P. Vivax Infection [EARLY_Phase 1]

View source ↗

Summary

This update reports completion of VAC069, a Phase 1 study evaluating blood-stage controlled human Plasmodium vivax infection, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Vivax Malaria

Snippet

Sponsor: University of Oxford | Conditions: Malaria, Vivax | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-04-25